Quality Of Life Outcomes Following Treatment for Esophageal Cancer

Completed

• Conditions: Esophageal Cancer
• Interventions: Behavioral: Questionnaires

• Registration Number: NCT00598117
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.

Detailed Description

In order to determine the impact of esophageal cancer and its treatment on patients' quality of life over time, this study will prospectively follow a cohort of patients at specified intervals, evaluating their physical symptoms, physical and social functioning and overall quality of life. Medical and sociodemographic factors as well as health behaviors that might be predictive of adaptation will be tested. This is a preliminary investigation and it is hoped that we will be able to base future research questions on the results of this study.

Study Timeline

• Study Start: 2003-08
• Study First Submitted: 2008-01-09
• Study First Submitted QC: 2008-01-09
• Study First Posted: 2008-01-18
• Status Verified: 2013-06
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Last Update Submitted: 2013-06-26
• Last Update Posted: 2013-06-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 409

Inclusion Criteria

• Age 18 or older
• Diagnosis of esophageal cancer.
• Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal, McKeown procedure) of esophageal cancer. (Group 1 patients only)
• Underwent esophagectomy for esophageal cancer at least 18 months prior to consent, with no evidence of disease. (Group 2 patients only)
• Ability to speak, read and write English.

Read More

Exclusion Criteria

• Inability to give informed consent.
• Patients anticipated to require a laryngectomy as part of their surgical resection.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	Questionnaires	Group 1 (newly diagnosed patients) Initial assessment → first post op visit → 6 and 12 months post surgery
2	Questionnaires	Group 2 (post-treatment patients) A one-time assessment will be conducted at least 18 months following treatment

Primary Outcome Measures

Name	Time	Method
To prospectively evaluate the quality of life of patients before and after esophageal cancer resection.	Initial assessment → first post op visit → 6 and 12 months post surgery

Secondary Outcome Measures

Name	Time	Method
To describe a cohort of long term survivors of esophageal cancer in order to identify significant features in patients more than 18 months post surgery.	18 months following treatment

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States